Dec. 27 at 4:44 AM
$BEAT "The synthesized 12-L ECG output is solely intended for manual assessment of normal sinus rhythm and the
following non-life-threatening arrhythmias: sinus arrhythmia, sinus tachycardia, sinus bradycardia, atrial
premature complexes, atrial fibrillation, and ventricular premature complex. The synthesized 12-L ECG output
is not intended for the assessment of any other arrhythmia or conditions (including but not limited to: other
atrial arrhythmias, ventricular arrhythmias, hypertrophy, conduction disorders, myocardial infarction or
ischemia, pacemaker functions, localization of arrhythmia foci, ECG wave abnormalities, and/or any other
disorder). The software does not conduct cardiac analysis and is not intended to replace a standard 12-L ECG."
https://cdn.prod.website-files.com/60c8eb9ac80e9635cdb48ef3/6939082837e447c905660645_D-10001%20HeartBeam%20AIMIGo%20Patient%20User%20Manual%20%28Rev6%29.pdf
Small steps. It will take a lot more money and a lot more studies to get the product to where Heartbeat has envisioned. It will be difficult to convince clinicians to use the device over an Apple Watch which suggests HTN.
